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Applying a Metabolic Footprinting Approach to 
Characterize the Impact of the Recombinant 
Protein Production in Escherichia coli  
Sónia Carneiro*, Silas G. Villas-Bôas, Isabel Rocha, and Eugénio C. Ferreira 
Abstract. In this study metabolic footprinting was applied to evaluate the metabolic 
consequences of protein overproduction at slow growth conditions (μ = 0.1 h-1). The 
extracellular metabolites detected by gas chromatography-mass spectrometry char-
acterized the metabolic footprints before and after the induction of the recombinant 
protein production (i.e. pre- and post-induction phases). Metabolic footprinting en-
abled the discrimination between the two growth phases and exposed significant al-
terations in the extracellular milieu during the recombinant process.  
1   Introduction 
Escherichia coli has been exploited for the production of a variety of products, es-
pecially recombinant proteins with pharmaceutical applications. Vast efforts have 
been made to improve the productivity of such bioprocesses, like the optimization 
of operational conditions, medium composition and the implementation of moni-
toring and control strategies [11,12,21]. However, the overproduction of these re-
combinant products often causes cellular stress events that result in slow growth 
and eventually cessation of growth [2,3,8,18]. The rapid exhaustion of essential 
metabolic precursors and cellular energy due to the expression of recombinant 
proteins may result in the imbalance of the metabolic load in the host cell, also 
called metabolic burden [9]. It is believed that the withdrawal of the intermediates 
that serve as biochemical precursors explains the decreasing tricarboxylic acid 
(TCA) cycle activity and consequent acetate production that has been reported in 
many works [1,5-7,10,22,23,25].  
In recent years, various high-throughput experimental techniques have been 
used to understand the physiological behavior of cells during the operation of 
these bioprocesses and to develop strategies to overcome some of these limita-
tions, like the design of improved strains that maximize the yield or productivity 
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of recombinant proteins [4,14]. Transcriptome and proteome analyses have been 
widely used to investigate the stress response mechanisms associated with over-
production of recombinant proteins in E. coli, but so far metabolomic approaches 
were scarcely exploited in the characterization of recombinant cultures. Metabolic 
footprinting, i.e. the analysis of the entire set of metabolites released from cells 
into the extracellular medium, can be an effective method to characterize the 
metabolic state of cells at diverse environmental conditions. The secretion of me-
tabolites during the production of recombinant proteins may reflect the adjustment 
of the intracellular metabolism in response to the imposed metabolic demands 
[13], since the intracellular accumulation of certain metabolites due to metabolic 
imbalances will most probably result in their excretion. Therefore, metabolic foot-
printing can represent an invaluable tool to generate key information that, together 
with other experimental data, will help in the optimization of recombinant  
cultures. 
In this study, we investigated the usefulness of metabolic footprinting to assess 
the impact of the induction of recombinant protein production in E. coli cells. To 
avoid overlapping cellular responses that could be triggered, for example by meta-
bolic overflow, cellular growth was maintained at low rates through the control of 
the glucose feeding profile.  
2   Material and Methods 
2.1   Growth Conditions 
The E. coli strain W3110 (F-, LAM-, IN[rrnD-rrnE]1, rph-1) was transformed 
with the cloned pTRC-HisA-AcGFP1 plasmid encoding the production of the re-
combinant AcGFP1 protein. The gfp gene was amplified from the pAcGFP1 
plasmid (from Clontech) that encodes for the green fluorescent protein AcGFP1, a 
derivative of AcGFP from Aequorea coerulescens.  
Cells were first grown in a shake flask pre-culture using minimal medium con-
sisting of 5 g·kg-1 of glucose, 6 g·kg-1 of Na2HPO4, 3 g·kg-1 of KH2PO4, 0.5 g·kg-1 
of NaCl, 1 g·kg-1 of NH4Cl, 0.015 g·kg-1 of CaCl2, 0.12 g·kg-1 of MgSO4.7H2O, 
0.34 g·kg-1 of thiamine, 2 mL·kg-1 of trace-element solution (described elsewhere 
[16], 2 mL·kg-1 of vitamins solution (described elsewhere [16]), 20 mg·kg-1of L-
isoleucine and 100 mg·kg-1 of ampicillin. For fed-batch cultures, cells were there-
after transferred to a fermenter with the same minimal medium, except glucose. 
The feeding medium consisted of 50 g·kg-1 of glucose, 10 g·kg-1 of NH4Cl, 4 g·kg-
1
 of MgSO4.7H2O, 20 mg·kg-1of L-isoleucine and 100 mg·kg-1 of ampicillin.  
Fed-batch fermentation was conducted in a 5L fermenter (Biostat MD) with a 
working volume of 2 L at 37ºC, pH 7 and dissolved oxygen (DO) above 30%. The 
induction of AcGFP1 protein production was performed with 1.5 mM IPTG (iso-
propyl β-D-thiogalactoside) when the culture reached an optical density 
(OD600nm) of 2.3. Fermentation conditions were monitored and controlled via a 
computer supervisory system. A closed-loop feeding control algorithm was em-
ployed to maintain the growth rate (µ) constant in the fed-batch culture [17]. The  
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algorithm is based on a Monod kinetic model using glucose as the only growth-
limiting substrate and can be represented by the following equation: 
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To maintain the specific growth rate (µ) at 0.1h-1, the feeding profile was com-
puted based on the growth yield in glucose (YX/S) that was set to 0.35 and the con-
centration of glucose in the feed (Sf), kept at 50 g·kg-1. The culture medium weight 
(WR) was measured online, while the biomass concentration (X) was estimated 
based on the initial concentration.  
2.2   Analytical Methods 
Samples were taken from the fermenter approximately every 30 minutes for the 
determination of OD600nm, AcGFP1 fluorescence, glucose and acetate concentra-
tions and the GC-MS analysis of extracellular amino and nonamino organic acids. 
In order to determine the cell dry weight, 10 mL of broth were centrifuged at 
10000 g for 20 min at 4ºC, washed twice with deionized water and dried at 105 °C 
to constant weight. The production of AcGFP1 was determined by fluorescence 
measurements at a Jasco FP-6200 spectrofluorometer with excitation and emission 
wavelengths of 475 and 505 nm, respectively, a bandwidth of 10 nm and a high 
sensitivity response in 0.1 seconds. His-Tag purification of the AcGFP1 was per-
formed with HiTrap columns (GE Healthcare Bio-Sciences AB) and the concen-
tration was determined by the Bradford method using BSA as standard. The meta-
bolic footprints were analyzed by GC-MS. After the lyophilization of 1 mL of 
each sample in triplicates, chemical derivatization was performed using the methyl 
chloroformate (MCF) method described elsewhere [26]. Samples were thereafter 
analyzed with a GC-MS system – a GC7890 coupled to an MSD5975 - (Agilent 
Technologies) equipped with a ZB-1701 GC capillary column, 30 m x 250 mm id 
x 0.15 mm (film thickness) with 5 m guard column (from Phenomenex), at a con-
stant flow rate of 1.0 mL/min of helium. Samples (1 µL) were injected onto the 
column under pulsed splitless mode (1.8 bars until 1 min, 20 mL/min split flow af-
ter 1.01 min) and the detector was set with a scan interval of 1.47 seconds and m/z 
range of 38-650. 
2.3   Data Processing and Statistical Analysis 
The mass fragmentation spectrum was analyzed with the Automated Mass Spec-
tral Deconvolution and Identification System (AMDIS) [24] to identify the me-
tabolites matching the analytical chemical standards. The peak intensity values of 
the identified metabolites in the spectrum were normalized by the peak intensity of 
the internal standard (D-4-alanine) and the corresponding biomass concentration 
of the sample. Further data processing and statistical analysis were performed with  
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MultiExperiment Viewer (MeV) v4.5 [20]. The normalized peak intensity values 
were log2 transformed and further computed using K-means clustering (KMC), hi-
erarchical clustering (HCL), and principal component analysis (PCA). K-means 
method was used to group the metabolic profiles into k clusters, while hierarchical 
clustering distributed samples and metabolites into branched groups represented 
by a two dimensional tree. Euclidean distance metrics were used in both clustering 
methods. PCA was further used to visualize whether the samples could be differ-
entiated based on their metabolic profiles. 
3   Results 
In this study the impact of the production of recombinant proteins in the E. coli 
metabolism was investigated. The resulting growth pattern (Figure 1) shows  
that the biomass formation was affected by the AcGFP1 production, since before 
the IPTG-induction the experimental growth rate (0.16 h-1) was higher than  
the growth rate imposed by the feeding profile. In turn, after IPTG induction the 
estimated biomass concentration was closer to the experimentally determined,  
corresponding to a growth rate of approximately 0.09 h-1. This suggests that the 
biomass yields from glucose (YX/S) in the two growth phases were considerably 
different. In the first phase (pre-induction) glucose entering the cell was used for 
growth and maintenance, while in the second phase (post-induction) glucose was 
also allocated to AcGFP1 formation.  
 
 
Fig. 1 Growth profile of the recombinant E. coli during the controlled fed-batch fermenta-
tion. a) The biomass formation and the AcGFP1 production were monitored in the pre- and 
post-induction phases. The dashed arrow indicates IPTG addition to the culture and the 
other arrows point to the samples analyzed in the GC-MS. Samples were identified by the 
letters A and B, corresponding to the pre- and post induction phases, respectively. b) The 
feeding profile generated by the model was periodically updated for the estimated biomass 
concentration 
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Fig. 2 Analysis of the metabolic footprints. a) Hierarchical clustering (HCL) defined clus-
ters in the sample and metabolite dimensions. b) Principal component analysis (PCA) 
grouped samples from the pre-indution phase (group A) isolated from samples taken after 
IPTG-induction (group B). c) K-Means Clustering (KMC) gives the resulting clusters based 
on the KMC input parameters (50 interactions upper limit). Metabolite abbreviations: cbm - 
carbamic acid; 2paac - 2-phenylaminoacetic acid; ocdca – stearic acid; fum – fumaric acid; 
bnz – benzoic acid; succ – succinic acid; acon-C – cis-aconitic acid; mlt – malonic acid; 
glu-L – L-glutamic acid; asp-L – L-aspartic acid; 4hbz - hydroxybenzoic acid; itcon – ita-
conic acid 
Since the experiments were performed at slow growth, no acetate was accumu-
lated. However, unexpected metabolites were detected in the extracellular medium 
during the fed-batch experiment. According to the GC-MS results, important dif-
ferences were identified in the metabolic footprints in both growth phases: pre-
induction (phase A) and post-induction (phase B).  
Results from HCL and PCA analyses (Figure 2a and 2b) show that samples 
taken during phases A and B presented distinct metabolic footprints. Although 
HCL shows that samples B5 cluster in a small sub-branch, it is clear that the me-
tabolic footprints sampled before IPTG-induction (phase A) are distinct from 
those sampled after IPTG-induction (phase B). This was also confirmed by the 
PCA graph that assigned samples into two major groups corresponding to the 
growth phases. Further examination of the clusters generated by the K-means me-
thod (Fig. 2c) reveals that some metabolites presented similar profiles along the 
fermentation process. For example, cluster 2 was characterized by the extracellular 
accumulation of cis-aconitic acid (acon-C) and malonic acid (mlt) immediately af-
ter the IPTG induction, while metabolites within cluster 1 were secreted approxi-
mately two hours later, when the AcGFP1 production was most evident. Carbamic 
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acid (cbm), involved in the production of a source of nitrogen for E. coli growth, 
was the only metabolite that did not cluster with any other metabolite.  
4   Discussion and Conclusions 
Both PCA and HCL analyses indicate that the recombinant protein production in 
E. coli has a high impact in the cellular metabolism. Several metabolites were se-
creted into the medium after IPTG induction, in particular metabolites that were 
collected within clusters 1 and 2. For the other metabolites, it is not possible to 
discern if their profiles were influenced by the production of recombinant protein 
or by the changing fed-batch conditions (biomass concentration increases during 
the experiment). However, metabolites collected in clusters 1 and 2 are more like-
ly to be modulated by the recombinant process since the accumulation of these 
metabolites was only observed in phase B. 
The accumulation of cis-aconitic acid, that participates in the TCA cycle and 
two other amino acids, which precursors are TCA intermediates, such as the L-
glutamic and L-aspartic acids that are synthesized via the enzymatic conversion of 
the α-ketoglutaric and oxaloacetic acids, respectively, suggest that this pathway is 
notably affected by the production of the recombinant protein. As reported 
[15,19], the metabolic effects imposed by the plasmid maintenance and formation 
of the recombinant product were found to be associated with the metabolic burden 
caused by the withdrawal of some metabolic intermediates that serve as biochemi-
cal precursors. As a consequence, the activity of many biochemical pathways is 
affected and it is frequently observed a decrease in the TCA cycle activity and the 
production of by-products that, at high concentrations, might be toxic to the cells. 
Therefore, by unbalancing the activity of certain reactions, it is expected that some 
metabolites are accumulated and subsequently secreted into the extracellular me-
dium. This supports the idea that the metabolic adjustments required to compen-
sate the additional production of a recombinant product are not as efficient as de-
sired from a bioprocess optimization perspective. 
Although the metabolic footprint measurements are not entirely informative, 
since they do not provide a comprehensive analysis of the intracellular metabolic 
changes, they can be used as variables in a multivariate statistical process control, 
like dynamic principal component analysis, for the on-line bioprocess monitoring. 
Ultimately, this information can help to characterize the physiological state and 
culturing performance during recombinant processes. From an engineering point 
of view, it is crucial to operate these processes in order to achieve consistent and 
reproducible qualities by developing modeling strategies using real-time observa-
tion of process variables, and furthermore to detect in advance abnormal produc-
tion conditions. 
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